CLCollPlant Biotechnologies Ltd. CLGN · NASDAQ
$3.62 -3.60% (-$0.14)
- Market cap
- $4.69M
- Enterprise value
- $4.40M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 14.8x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -221.3%
- Gross margin
- -521.7%
- Net margin
- -3,934.9%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 0.76
- Free float
- 75.8%
About the company
CollPlant Biotechnologies Ltd. (CLGN) is a biotechnology company operating in the field of regenerative medicine. The company focuses on the development and production of biological materials and collagen-based products for the treatment of various health conditions. CollPlant employs advanced technologies in creating bioinks and 3D printing for tissue and organ generation. The company emphasizes innovation and product development that could contribute to improvements in patient care. CollPlant Biotechnologies Ltd. (CLGN) shares could be an intriguing choice for investors interested in the biotechnology sector and regenerative medicine.
Sector
Healthcare
Industry
Biotechnology
CEO
Yehiel Tal
Employees
39
Headquarters
Rehovot
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number